BRAIN AND COGNITION, published by Academic Press Inc Elsevier Science, stands as a vital resource for researchers and practitioners in the realms of cognitive neuroscience and psychology. Established in 1982, the journal has continuously evolved, showcasing cutting-edge research that bridges the understanding of brain functions and cognitive processes up to 2024. With an impressive impact factor reflecting its commitment to high-quality scholarship, the journal currently holds a prestigious Q1 ranking in Arts and Humanities (miscellaneous) and notable Q2 rankings in various psychology fields, including Cognitive Neuroscience, Developmental and Educational Psychology, Experimental and Cognitive Psychology, and Neuropsychology. This multidisciplinary journal cultivates a rich academic dialogue, offering valuable insights to professionals, researchers, and students alike. Although it does not offer open access, its robust indexing in Scopus and consistent contribution to important discussions in cognitive research define its critical role in advancing knowledge and innovation in the cognitive sciences.

CEREBRAL CORTEX, published by Oxford University Press Inc, is a premier journal dedicated to advancing the field of neuroscience, specifically focusing on the cellular, molecular, and cognitive aspects of cortical structure and function. With an impressive impact factor that situates it in the top quartile (Q1) of its categories for 2023, this journal holds significant relevance for researchers and professionals interested in the latest discoveries and methodologies in both Cognitive Neuroscience (ranked #31 out of 115) and Cellular and Molecular Neuroscience (ranked #48 out of 97). Operating without an open access model, it ensures rigorous peer review and dissemination of high-quality research from across the globe. Since its inception in 1991, CEREBRAL CORTEX has established itself as a critical platform for educators and inventors, pushing the boundaries of knowledge in understanding brain function and its implications for behavior. Researchers and students alike will find this journal an invaluable resource for both foundational and cutting-edge studies in neuroscience.

Nature Aging, published by SPRINGERNATURE in Germany, stands as a premier journal dedicated to advancing the field of aging research. With high-ranking performance indicators, including a Q1 classification in Aging, Geriatrics and Gerontology, and Neuroscience (miscellaneous), this journal emphasizes the interdisciplinary nature of aging studies. Its Scopus rankings highlight its impact, achieving remarkable positions such as #1 in Neuroscience and #2 in both Geriatrics and Biochemistry for aging-related research. Although currently not open access, Nature Aging provides a wealth of cutting-edge research and critical reviews that aid researchers and practitioners in understanding the complexities of aging mechanisms and their implications. As the field continues to evolve from 2021 through 2024, this journal not only facilitates the dissemination of knowledge but also fosters innovative discussions that propel the science of aging forward. Join the vibrant community of scholars and professionals dedicated to solving the challenges associated with aging by engaging with the content published in Nature Aging.

Frontiers in Aging is a leading academic journal published by FRONTIERS MEDIA SA, dedicated to advancing the understanding of the biological processes associated with aging. Established in 2020, this open-access journal aims to bridge the gap between various disciplines including genetics, molecular biology, and physiology, providing a multidisciplinary platform for researchers and clinicians alike. With a notable impact factor denoted by its Q2 quartile rankings in Aging, Genetics, and Molecular Biology, and a Q1 ranking in Physiology as of 2023, the journal is recognized for its contribution to the scientific community. Located in Lausanne, Switzerland, it is committed to promoting open discourse and publishing cutting-edge studies that address the complexities of aging and its implications for health and longevity. The journal’s editorial board, consisting of leading experts, ensures the rigorous peer-review process, maintaining high academic standards and fostering innovation in aging research.

Brain Connectivity is a premier journal dedicated to advancing the understanding of neural connections and brain function through innovative research and interdisciplinary collaboration. Published by MARY ANN LIEBERT, INC, this journal has established itself in the field of neuroscience, earning a respectable Q2 ranking in the 2023 category of Neuroscience (Miscellaneous) and a Scopus rank of 61 out of 113 in General Neuroscience. Since its inception in 2011, Brain Connectivity has been at the forefront of research on the intricate web of brain networks, exploring topics such as functional connectivity, neuroimaging, and the implications of connectivity studies for understanding various neurological disorders. Researchers, professionals, and students benefit from comprehensive access to cutting-edge studies and critical reviews, fostering a deeper appreciation of brain dynamics. As the field evolves, Brain Connectivity remains a vital resource for those aiming to contribute to our growing understanding of brain architecture and function.

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS is a distinguished peer-reviewed journal published by KARGER, based in Switzerland. With a focus on the critical fields of cognitive neuroscience, geriatrics, and psychiatry, this journal is integral to advancing our understanding of cognitive decline and geriatric health. Despite being established from 1990 through 1992 and relaunching its scope in 1994, it has consistently provided a platform for innovative research, as reflected in its strong impact factor and notable Scopus rankings, placing it in the Q2 quartile for disciplines including cognitive neuroscience and geriatric medicine. The journal aims to foster interdisciplinary dialogue and collaboration among researchers, healthcare professionals, and educators, contributing to the growing field of dementia research and elderly care. Open access options further ensure that this vital knowledge is widely accessible, making a significant impact in both academic and clinical settings. With a commitment to quality and relevance, DEMENTIA AND GERIATRIC COGNITIVE DISORDERS remains a key resource for those dedicated to understanding and addressing the challenges posed by cognitive disorders in aging populations.

Aging Clinical and Experimental Research, published by Springer, is a premier journal dedicated to advancing the field of geriatric medicine and understanding the complexities of aging. With a commitment to publishing high-quality original research, review articles, and clinical studies, this journal plays a crucial role in disseminating knowledge to researchers, healthcare professionals, and students interested in the biological, clinical, and social aspects of aging. Boasting a 2023 impact factor that places it in the Q2 quartile for both Aging and Geriatrics and Gerontology categories, it ranks favorably within the Scopus metrics—20th out of 116 in Geriatrics and Gerontology and 15th out of 38 in Aging. The journal provides vital insights for the ongoing discourse in aging research, making it an essential resource for those seeking to enhance their understanding of aging-related phenomena and improve healthcare outcomes across populations. The converged years of publication from 1989 to 2024 demonstrate its longstanding commitment to the field, highlighted by its notable presence in Germany and access to a broad international readership.

JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY, published by SAGE PUBLICATIONS INC, is a premier academic journal dedicated to advancing the understanding of mental health issues and neurological disorders in the aging population. With an established presence since 1988, this journal stands out in the fields of Geriatrics, Gerontology, Neurology, and Psychiatry, currently positioned in the Q2 category based on 2023 metrics, reflecting its influence and academic rigor. The journal is indexed in major databases and is highly regarded for its contributions, as evidenced by its strong Scopus rankings. It serves as an essential resource for researchers, clinicians, and students, offering insightful articles that explore the complex interplay between aging, mental health, and neurological conditions. Although it does not provide open access, it continues to be a vital source of scholarly knowledge for those dedicated to enhancing the well-being of the elderly population.

EXPERIMENTAL AGING RESEARCH, published by Taylor & Francis Inc., is a leading journal that has been at the forefront of aging research since its inception in 1975. With an ISSN of 0361-073X and an E-ISSN of 1096-4657, this journal has earned a notable reputation, including a Q3 ranking in the field of Aging and impressive Q1 and Q2 rankings in Arts and Humanities and Geriatrics and Gerontology respectively. This positions the journal within the top percentile of its category, highlighting its significant impact and contribution to the scientific community. Covering a broad scope that intersects various disciplines, EXPERIMENTAL AGING RESEARCH aims to disseminate pioneering research, foster interdisciplinary collaboration, and provide a platform for innovative studies that enhance understanding of the aging process. While it currently does not offer Open Access, researchers and academics can access its rich repository of knowledge that spans multiple facets of aging, from physiological changes to psychological impacts. As the field of aging continues to evolve, this journal remains an essential resource for researchers, professionals, and students dedicated to advancing knowledge and practices concerning aging and longevity.

METABOLIC BRAIN DISEASE, published by SPRINGER/PLENUM PUBLISHERS, is a leading journal dedicated to advancing our understanding of the metabolic processes impacting brain health and disease. Established in 1986 and set to continue until 2024, this journal encompasses a wide range of interdisciplinary research that intersects the fields of Biochemistry, Cellular and Molecular Neuroscience, and Neurology, as evidenced by its notable quartile placements in Q2 and Q3 for 2023. With an ISSN of 0885-7490 and an E-ISSN of 1573-7365, it serves as a vital resource for researchers and practitioners aiming to deepen their insights into cerebral metabolic disorders and their implications. Although currently not an Open Access option, its rigorous peer-review process ensures that high-quality, impactful research reaches its audience. Showcasing a significant rank within the top percentile of its categories, METABOLIC BRAIN DISEASE is instrumental in shaping the future of neurological research and clinical applications.